Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 28, 2023
[The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project]Y Belkacemi, K Debbi, C Besnard, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 16, 2019
[French ccAFU guidelines - Update 2018-2020: Prostate cancer]F Rozet, C Hennequin, J-B Beauval, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 6, 2018
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancerF Rozet, C Hennequin, J-B Beauval, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 21, 2014
[Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients]S Servagi-Vernat, P Giraud, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Pageof 15